Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Aurobindo Pharma has obtained manufacturing approval from the US FDA for Quinapril Tablets USP 5mg, 10mg, 20mg and 40mg.
Subscribe to our email newsletter
Quinapril Tablets USP 5mg, 10mg, 20mg and 40mg is the generic version of Pfizer Pharmaceuticals’ Accupril Tablets 5mg, 10mg, 20mg and 40mg respectively.
The product that falls under the cardiovascular (CVS) therapeutic category has been indicated for the treatment of hypertension.
The US regulator approved the product out of Unit VII (SEZ) formulations facility in Hyderabad, India.
Indian-based Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients in facilities
approved by several regulatory agencies like USFDA, UK MHRA, WHO, Health Canada, MCC South Africa, ANVISA Brazil.